Heron Therapeutics (HRTX) Total Debt (2016 - 2025)
Historic Total Debt for Heron Therapeutics (HRTX) over the last 5 years, with Q3 2025 value amounting to $107.5 million.
- Heron Therapeutics' Total Debt rose 33292.65% to $107.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $107.5 million, marking a year-over-year increase of 33292.65%. This contributed to the annual value of $25.0 million for FY2024, which is 314.47% up from last year.
- According to the latest figures from Q3 2025, Heron Therapeutics' Total Debt is $107.5 million, which was up 33292.65% from $25.2 million recorded in Q1 2025.
- In the past 5 years, Heron Therapeutics' Total Debt ranged from a high of $107.5 million in Q3 2025 and a low of $24.0 million during Q3 2023
- Moreover, its 3-year median value for Total Debt was $24.7 million (2024), whereas its average is $35.0 million.
- Examining YoY changes over the last 5 years, Heron Therapeutics' Total Debt showed a top increase of 33292.65% in 2025 and a maximum decrease of 313.33% in 2025.
- Heron Therapeutics' Total Debt (Quarter) stood at $24.3 million in 2023, then rose by 3.14% to $25.0 million in 2024, then soared by 329.5% to $107.5 million in 2025.
- Its Total Debt was $107.5 million in Q3 2025, compared to $25.2 million in Q1 2025 and $25.0 million in Q4 2024.